Vaccine Development, specializing in protein science and adjuvant technology to speed safe and highly effective vaccines from the bench through clinical development.www.curevovaccine.com

Business, alliance, and market entry strategy for firms in immunotherapy, oncology, diagnostics, medical devices, and neurocognitive disorders.

Founded HealthLink Global, an open-architecture data interchange platform & hub for the healthcare industry to support information flows and business applications.Target customers include: hospitals, manufacturers, healthcare exchanges (VANs), government agencies.

M&A, Joint Ventures, Strategic AlliancesICT-Healthare convergence business building through organic and inorganic growth and strategic partnerships across Asia.Active in healthcare services, IVD, mHealth, AI, digital health

This was a great experiencing in building the Multinational Supplier business unit. I built a team to launch strategic initiativess in collaborative Inventory Management, eBusiness in Healthcare Diagnostics and Sales Rep Scanning Solutions.This business unit grew from 20% of EU revenues to accounting for over 50% of revenues.Strategic Alliances with Medical Device Manufacturers & Pharmaceutical Industry

Advised this not-for-profit on healthcare strategy and strategic alliances (members include pharma, medical device, distributors, regulatory agencies, GPOs and hospitals), managed integration of disparate healthcare activities and represented GS1 US on academic issues.Worked with GS1 & the World Customs Organization (WCO) to develop a joint strategy paper that resulted in a Memorandum of Understanding between the two organizations.Developed market evaluation criteria and assessed high-tech, chemical, customs, and fresh-foods sectors.Advised on entry into sustainability for Retail-FMCG.Key Stakeholders: Medical Device Manufacturers, Pharmaceutical Industry, GPOs, Distributors, Regulatory Authorities

I was brought in by NBG Venture Capital to set up Forth Photonics as a Medical Imaging Company.Created the UK Holding and Greek Subsidiary and positioned the company for FDA & CE Marking Approval.

As part of the global launch of the our neurovascular coil business we created a new business unit in Europe. This was an exciting time to hire and bring together a great team to tackle a new market.

After my MBA at INSEAD, my first sales and marketing position was to stabilize and redress this division. The transition into general management was a steep learning curve for me but in the end the division came out stronger and well positioned for the future.I got my first taste of new business development here as we deployed programmes to enter the biliary stent market and systematically develop the practice of uterine fibroid embolization through medical faculty workshops and training.

My first experience with medical devices; the stent business was the wild-west of healthcare: highly competitive, constant innovation; a very dynamic business. Joining J&J at this time was an incredible opportunity for me as I was one of the first in Europe to apply a systematic approach to pricing and reimbursement negotiations in the devices business. An exciting and very rewarding experience.

First job in Health Economics. I joined a diverse and young team of bright and highly motivated professionals to lead the way for Ciba-Geigy in maximizing the use of economic data for pricing and reimbursement. My boss, Jean-Michel Cosséry was a real inspiration to me.